[VIVO] QoQ Quarter Result on 31-Dec-2021 [#Q1]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
04-Feb-2022
Financial Year
2022
Quarter
31-Dec-2021 [#Q1]
Profit Trend
QoQ- 130.43%
YoY- -42.72%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 65,675 67,771 111,231 88,341 76,204 63,511 85,264 -15.95%
PBT 4,633 -6,602 36,535 19,751 7,856 15,295 33,052 -72.98%
Tax -1,072 736 7,783 4,411 1,199 3,626 6,750 -
NP 5,705 -7,338 28,752 15,340 6,657 11,669 26,302 -63.86%
Tax Rate 23.14% - -21.30% -22.33% -15.26% -23.71% -20.42% -
Total Cost 59,970 75,109 82,479 73,001 69,547 51,842 58,962 1.13%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 8.69 -10.83 25.85 17.36 8.74 18.37 30.85 -56.99%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS 0.13 -0.16 0.65 0.35 0.15 0.27 0.61 -64.28%
EPS Diluted 0.13 -0.16 0.65 0.35 0.15 0.26 0.60 -63.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.